Compare ORGO & AMWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORGO | AMWL |
|---|---|---|
| Founded | 1985 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.0M | 179.6M |
| IPO Year | 2016 | 2020 |
| Metric | ORGO | AMWL |
|---|---|---|
| Price | $1.00 | $11.68 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 7 |
| Target Price | $2.00 | ★ $12.80 |
| AVG Volume (30 Days) | ★ 601.6K | 82.1K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1600.00 | 57.06 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $564,169,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $37.55 | $3.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 17.04 | N/A |
| 52 Week Low | $1.10 | $3.71 |
| 52 Week High | $7.08 | $14.19 |
| Indicator | ORGO | AMWL |
|---|---|---|
| Relative Strength Index (RSI) | 18.64 | 38.30 |
| Support Level | N/A | $11.23 |
| Resistance Level | $2.69 | $13.92 |
| Average True Range (ATR) | 0.06 | 0.72 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 0.00 | 11.25 |
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.